Tate & Lyle's innovative ingredients can help food and beverage manufacturers tackle global diabetes epidemic

| Filed in:

New glycaemic response white paper from Tate & Lyle explores the role food and beverage manufacturers can play in developing products that help consumers manage blood glucose while following dietary guidelines

Glycaemic response white paper email

London, UK, 14 November 2019: Tate & Lyle PLC (Tate & Lyle), a leading global provider of food and beverage ingredients and solutions, is proud to work with customers worldwide to improve the healthiness of the food supply. Diabetes affects over 425 million people globally (Source: International Diabetes Federation) and today’s World Diabetes Day provides food and beverage businesses with an opportunity to consider what more they can do to support global efforts to tackle Type II diabetes.

Given public health concerns surrounding the high incidence of diabetes and metabolic syndrome, managing blood glucose is very important. Tate & Lyle has published a white paper which explores the diabetes epidemic, dietary interventions and the role food and beverage manufacturers can play in developing products to help consumers manage blood glucose. It also looks at how Tate & Lyle’s innovative ingredients, such as fibres, rare sugars, and low and non-nutritive sweeteners, can help address glycaemic response in food and beverage products.

Dr. Kavita Karnik, VP Global Nutrition at Tate & Lyle, said:

"We believe people should be able to make healthy food and drink choices by having access to low calorie, low sugar and high fibre options. That's why we have a range of ingredients that food and beverage producers can use to make the products that, ultimately, could help prevent or manage incidences of Type II diabetes around the globe. We partner with our customers to help them not only achieve great tasting foods and beverages, but also to improve lives, and helping to prevent Type II diabetes with our ingredients is just one way we’re doing this."

Tate & Lyle’s range of fibres and sweeteners can help food and beverage manufacturers produce lower calorie, high fibre options for consumers that can help keep blood sugar at healthy levels, without compromising taste.

Tate & Lyle’s soluble fibre products are shown to significantly lower postprandial blood glucose and insulin levels. They include PROMITOR® Soluble Fibre and STA-LITE® Polydextrose soluble fibre. Our portfolio of non-nutritive sweeteners are low or zero calorie, but maintain the desired sweetness otherwise provided by sugar. They include DOLCIA PRIMA® Allulose, SPLENDA® Sucralose, Stevia Sweeteners and PUREFRUIT™ Monk Fruit Extract.

Learn more about how we partner with our customers to achieve food and beverage formulation goals, such as reducing sugar and calories.

# # #

Note to Editors

Media contact:

Miriam Wilkens, VP Global Communications, Tate & Lyle PLC, [email protected]

Learn more from our white paper on Glycaemic Response

About Tate & Lyle: 
Tate & Lyle is a global provider of solutions and ingredients for food, beverage and industrial markets.

Tate & Lyle operates through two global divisions, Food & Beverage Solutions and Primary Products, supported by the Innovation and Commercial Development and Global Operations teams. Food & Beverage Solutions is focused on growth by building leading positions globally in the categories of beverages, dairy, and soups, sauces and dressings. Primary Products is focused on delivering steady earnings and generating cash.

Food & Beverage Solutions consists of: Texturants, including speciality starches; Sweeteners, including low- and no-calorie sweeteners; and a Health and Wellness portfolio comprising mainly speciality fibres; and Stabilisers and Functional Systems, which are bespoke ingredient blends that ensure foods retain their structure.

Primary Products consists of high-volume sweeteners, industrial starches and fermentation products (primarily acidulants).  It also sells co-products from the corn milling process as animal nutrition.

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2019, Tate & Lyle sales totalled £2.8 billion. For more information, please visit http://www.tateandlyle.com or follow Tate & Lyle on Twitter or Linkedin.